ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
34.00
+0.17 (0.50%)
At close: Jun 26, 2026, 4:00 PM EDT
34.00
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:36 PM EDT
ArriVent BioPharma Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for ArriVent BioPharma stock have an average target of 44.56, with a low estimate of 42 and a high estimate of 50. The average target predicts an increase of 31.06% from the current stock price of 34.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ArriVent BioPharma stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 11 | 12 | 12 | 12 | 12 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Maintains $45 | Buy | Maintains | $45 | +32.35% | Jun 4, 2026 |
| Citi | Citi | Buy Maintains $43 | Buy | Maintains | $43 | +26.47% | Jun 4, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $45 | Buy | Maintains | $45 | +32.35% | Jun 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $50 | Buy | Reiterates | $50 | +47.06% | Jun 1, 2026 |
| Truist Financial | Truist Financial | Buy Initiates $43 → $45 | Buy | Initiates | $43 → $45 | +32.35% | May 29, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
42.75M
EPS This Year
-4.02
from -4.32
EPS Next Year
-3.50
from -4.02
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 80.4M | |
| Avg | n/a | 42.7M | |
| Low | n/a | 1.5M |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 513.4% |
| Avg | - | 250.0% |
| Low | - | -67.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.32 | -2.19 | |
| Avg | -4.02 | -3.50 | |
| Low | -4.62 | -5.21 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.